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1. Introduction 
In addition to the well known active metabolites of 
vitamin D3, 25OHDa and 1 ,2S(OH)2 D3, two other 
dihydroxy derivatives of cholecalciferol have been 
isolated [ 1,2] from biological sources and identified 
[l-3] as 24,25- and 2S,26(OH)zDs. Their chemical 
synthesis was described recently by one of us [4-71 
and by others [8,9]. Unlike 25OH-Da and 1,25 
(OH),Ds, which act on gut and bone [ 10,111, the two 
other metabolites of cholecalciferol appeared to have a 
more selective activity. In vitamin D-deficient rats 
24,25- and 2S,26(0H)2DJ-induced a stimulation of 
intestinal calcium transport but not of bone calcium 
mobilization [9,12] . Under slightly different con- 
ditions, however, larger doses of both metabolites 
caused an increase in bone resorption [ 131. 
This apparent contradiction led us to investigate 
the action of 24,25- and 25,26(OH)*Da on bone 
resorption using a mouse bone culture system [ 141 
and to establish the log-dose response curve of doses 
up to 600 ng/ml in terms of calcium, phosphate and 
hydroxy-proline release. 
chemical synthesis as described elsewhere [4,6]. The 
compound is a mixture of diastereorsomeres 24 R and 
24 S in approximately equal proportions. 
25,26(OH)z Ds: The compound was prepared by 
chemical synthesis as described before [5,7] and con- 
sisted of a mixture of diasteroisomeres 25 R and 25 S 
in approximately equal proportions. 
Bone culture: The methods are those described 
previously [ 141. The calvaria from S- to 7-day old 
mice are cultured in BCJ, medium supplemented 
with 15% horse serum. After a 24 h equilibration 
period at 37°C in an atmosphere of 5% CO2 95% air, 
the medium is replaced by fresh medium, 2 ml/culture, 
which in the test vessels contain 25OHDs, 24,25 
(OH),Ds or 25,26(OH)*Da. The vitamin D metabolites 
are added to the culture medium dissolved in spectro- 
scopic ethanol (0.01 1.11/2 ml medium). Each experi- 
ment contains a control, a high and low dose of 25 
OHDs and at least 3 doses of 24,25(OH)~D3 or 25,26 
(OH)*Da. The response to the metabolites is calcu- 
lated as the mean change in medium calcium (7- 10 
calvaria) from the 7-10 control calvaria. 
3. Results 
2. Methods 
24,2S(OH)2D3: The metabolite was prepared by 
There is a log-linear response in bone resorption to 
concentrations of 25OHDa between 100 and 500 
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Fig.1. The log-dose response curves of mouse calvaria in tissue 
culture.to 25-OHD, (A), 25,26(OH),D, (0) and 24,25(OH),D, 
(0). The data have been combined from several experiments 
and are expressed as the mean change in medium calcium, 
umoles/ml f S.E.M., of the treated from the untreated calvaria. 
nglml (fig. 1). The metabolites 25,26(OH)2D3 and 
24,25(OH)zDa give a parallel response but at con- 
centrations above 300 ndml (fig. 1). A significant 
(p <O.OOl) increase, however, in bone resorption was 
given by 150 ng/ml of 24,25(OH)?Da whereas no 
response was seen with 123 &ml of 25,26(OH)?Da. 
The change in medium calcium is associated with a 
corresponding change in medium phosphate (Y = 0.99, 
p <O.OOl) and hydroxyproline (I = 0.85, p <O.OOl) 
and histology of treated calvaria showed an increase in 
resorption cavities as compared to control calvaria. 
4. Discussion 
The present results confirm that 25OHDs at con- 
centrations which are near to those found in human 
plasma, is very active in stimulating resorption in 
cultured bone [ 15,161. The natural metabolites 
24,25(OH)2D3 and 25,26(OH)2D3 present in plasma 
but at a lower concentration than 25OHDa, are also 
capable of resorbing bone. Both, however, are less 
potent than 25-OHDa. Reynolds et al. [ 161 showed 
that 24,25(OH)2D3 did not resorb bone but con- 
centrations higher than 50 ng/ml were not tested. The 
Table 1 
Effects of metabolites of vitamin D, on the release of calcium in the medium 
Vit. D. metabolite Concentration 
(nglml) 
Change in calcium 
~moles/ml 
(+ I S.E.M.) 
Mean f S.E.M. n P 
24,25(OH),D, 68 0.060 0.064 8 
75 0.061 0.054 8 
110 0.025 0.043 8 
150 0.165 0.022 8 
270 0.230 0.065 8 
300 0.117 0.042 7 
300 0.235 0.066 8 
400 0.193 0.037 8 
500 0.835 0.095 8 
600 0.938 0.071 8 
25,26(OH),D, 50 0.119 0.060 7 
100 0.020 0.043 8 
123 0.072 0.014 8 
300 0.269 0.077 7 
400 0.533 0.078 8 
518 0.905 0.064 8 
25-OHD, 100 0.237 0.030 39 
500 1.445 0.054 40 
<0.5 
<0.5 
<0.5 
<O.OOl 
<O.Ol 
<0.05 
<0.05 
<O.Ol 
<o.oo 1 
<O.OOl 
<o. 1 
<0.5 
<O.l 
<O.Ol 
<O.OOl 
<O.OOl 
<O.OOl 
<O.OOl 
p The p values give the significance of the difference from the controls (Students’ 
t - test). 
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hydroxyl group at the 25 position is important in the 
bone resorbing activity of vitamin D. So far we have 
found no vitamin D analogue with a 25 hydroxyl group 
which is unable to resorb cultured bone (personal 
data). It is clear, however, that hydroxylation at other 
sites can decrease or increase the bone resorbing 
activity. 
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